L. Belalcazar

Rebecca S. Blue, L. Belalcazar, C. Mathers, 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Nutrition and metabolism--sphingolipids and branched chain amino acids: indicators and effectors of adipose tissue function and diabetes risk.

C. Ballantyne, L. Belalcazar, 2011, Current opinion in lipidology.

Marine Omega-3 Fatty Acid Intake: Associations with Cardiometabolic Risk and Response to Weight Loss Intervention in The Look AHEAD Study Running title: Marine omega-3 fatty acid intake in Look AHEAD

D. Reboussin, S. Haffner, C. Ballantyne, 2009 .

Statin-Induced Diabetes: Will It Change Clinical Practice?

C. Ballantyne, V. Raghavan, L. Belalcazar, 2009, Diabetes Care.

Long-Term Stable Expression of Human Apolipoprotein A-I Mediated by Helper-Dependent Adenovirus Gene Transfer Inhibits Atherosclerosis Progression and Remodels Atherosclerotic Plaques in a Mouse Model of Familial Hypercholesterolemia

A. Beaudet, L. Pastore, L. Belalcazar, 2003, Circulation.

Aortic eNOS expression and phosphorylation in Apo-E knockout mice: differing effects of rapamycin and simvastatin.

L. Belalcazar, J. Naoum, G. Hunter, 2004, Surgery.

Fiber Intake and PAI-1 in type 2 diabetes: Look AHEAD Trial Findings at Baseline and Year 1

L. Belalcazar, A. Anderson, 2014 .

Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector

L. Belalcazar, L. Chan, A. Paul, 2007, Gene Therapy.

Response to Zhou et al. “Letter to the Editor: The effects of various intensities of physical activity and chronic inflammation in men and women by diabetes status in a national sample”

A. Kriska, C. Richardson, C. Ballantyne, 2013 .

Nonsevere Diabetic Ketoacidosis and Adrenal Insufficiency: Exploring the Impact of Glucocorticoid Replacement on Metabolic Outcomes and ICU Length of Stay

L. Belalcazar, Nicole Sheung, Arpita Beechar, 2020, Critical care explorations.

Comment on: Cohen et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420–1428

L. Belalcazar, Shwetha Thukunthla, 2013, Diabetes Care.

Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway.

Allan R Brasier, A. Brasier, I. Boldogh, 2004, Physiological genomics.

Defining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterol.

C. Ballantyne, L. Belalcazar, 1998, Progress in cardiovascular diseases.

Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD

W. Knowler, C. Ballantyne, G. Papandonatos, 2015, Circulation. Cardiovascular genetics.

Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.

A. Beaudet, Brendan H. Lee, L. Pastore, 2004, Gene.

A common variant in the CLDN7/ELP5 locus predicts adiponectin change with lifestyle intervention and improved fitness in obese individuals with diabetes.

D. Bowden, C. Ballantyne, G. Papandonatos, 2015, Physiological genomics.

Preoperative management of pheochromocytoma with severe orthostasis: Addressing the treatment challenge of dopamine co-secretion without alpha-blockade.

L. Belalcazar, Alexis L. McQuitty, Ruba Riachy, 2021, The American journal of medicine.

Marine Omega-3 Fatty Acid Intake: Associations with Cardiometabolic Risk and Response to Weight Loss Intervention in The Look AHEAD Study Running title: Marine omega-3 fatty acid intake in Look AHEAD

D. Reboussin, S. Haffner, C. Ballantyne, 2009 .

Do Genetic Modifiers of High-Density Lipoprotein Cholesterol and Triglyceride Levels Also Modify Their Response to a Lifestyle Intervention in the Setting of Obesity and Type-2 Diabetes Mellitus?: The Action for Health in Diabetes (Look AHEAD) Study

R. Wing, W. Knowler, L. Wagenknecht, 2013, Circulation. Cardiovascular genetics.

A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change

David M. Reboussin, Ron C. Hoogeveen, Christie M. Ballantyne, 2010, Diabetes Care.

Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study[S]

S. Haffner, C. Ballantyne, W. Lang, 2012, Journal of Lipid Research.

The effect of various intensities of physical activity and chronic inflammation in men and women by diabetes status in a national sample.

A. Kriska, C. Richardson, C. Ballantyne, 2012, Diabetes research and clinical practice.

Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: From the Look AHEAD Study

A. Kriska, S. Haffner, C. Ballantyne, 2013, Obesity.

SUN-492 Treatment of Uncontrolled Graves’ Disease Reveals Underlying Thyroiditis

L. Belalcazar, Nicole Sheung, 2020, Journal of the Endocrine Society.

Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression

L. Belalcazar, Pomila Singh, M. Quast, 2005, Cancer.